Literature DB >> 25958013

Extracellular vesicle microRNA transfer in cardiovascular disease.

Samarjit Das1, Marc K Halushka2.   

Abstract

microRNAs (miRNAs) are a class of small regulatory RNAs that decrease protein translation to fine-tune cellular function. Recently, miRNAs were found to transfer from a donor cell into a recipient cell via exosomes and microparticles. These microvesicles are found in blood, urine, saliva, and other fluid compartments. miRNAs are delivered with intact functionality and have been repeatedly shown to regulate protein expression in recipient cells in a paracrine fashion. Thus, transported miRNAs are a new class of cell-to-cell regulatory species. Exosomal miRNA transfer is now being reported in cardiovascular systems and disease. In the blood vessels, this transfer modulates atherosclerosis and angiogenesis. In the heart, it modulates heart failure, myocardial infarction, and response to ischemic preconditioning. This review describes our current understanding of extracellular vesicle miRNA transfer, demonstrating the roles of miR-126, miR-146a, miR-143, and other miRNAs being shuttled from endothelial cells, stem cells, fibroblasts and others into myocytes, endothelial cells, and smooth muscle cells to activate cellular changes and modulate disease phenotypes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Exosome; Microvesicle; miRNA

Mesh:

Substances:

Year:  2015        PMID: 25958013     DOI: 10.1016/j.carpath.2015.04.007

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  66 in total

Review 1.  Tiny Shuttles for Information Transfer: Exosomes in Cardiac Health and Disease.

Authors:  Raj Kishore; Venkata Naga Srikanth Garikipati; Anna Gumpert
Journal:  J Cardiovasc Transl Res       Date:  2016-02-24       Impact factor: 4.132

Review 2.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 3.  Toward the promise of microRNAs - Enhancing reproducibility and rigor in microRNA research.

Authors:  Kenneth W Witwer; Marc K Halushka
Journal:  RNA Biol       Date:  2016-09-19       Impact factor: 4.652

Review 4.  Mitochondrial pathways to cardiac recovery: TFAM.

Authors:  George H Kunkel; Pankaj Chaturvedi; Suresh C Tyagi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

5.  Exploring the mitochondrial microRNA import pathway through Polynucleotide Phosphorylase (PNPase).

Authors:  Danielle L Shepherd; Quincy A Hathaway; Mark V Pinti; Cody E Nichols; Andrya J Durr; Shruthi Sreekumar; Kristen M Hughes; Seth M Stine; Ivan Martinez; John M Hollander
Journal:  J Mol Cell Cardiol       Date:  2017-07-11       Impact factor: 5.000

Review 6.  Exosomes and Extracellular RNA in Muscle and Bone Aging and Crosstalk.

Authors:  Weiping Qin; Sarah L Dallas
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

Review 7.  MicroRNAs in platelet function and cardiovascular disease.

Authors:  David D McManus; Jane E Freedman
Journal:  Nat Rev Cardiol       Date:  2015-07-07       Impact factor: 32.419

8.  Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.

Authors:  Shyam Sundar Nandi; Paras Kumar Mishra
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

Review 9.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

10.  Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure.

Authors:  Changhai Tian; Lie Gao; Matthew C Zimmerman; Irving H Zucker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-01-26       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.